ICD-10-CM Billable Code

D3A.026

Benign carcinoid tumor of the rectum

Clinical Classification Guidelines

Medical Intelligence & Overview

A benign carcinoid tumor of the rectum is a non-cancerous growth that develops in the rectum, which is the final part of the large intestine. Although it is considered benign, it's important to monitor and manage the condition appropriately to prevent potential complications. Carcinoid tumors originate from neuroendocrine cells, which are responsible for producing hormones, and can sometimes produce substances that lead to specific symptoms.

Causes & Symptoms

Clinical Causes: Genetic factors that predispose individuals to develop neuroendocrine tumors. Random genetic mutations leading to abnormal growth of neuroendocrine cells. Potential environmental influences, although specific triggers are not well-understood. A family history of neuroendocrine tumors or related syndromes may increase risk.

Key Symptoms: Rectal bleeding or blood in the stool. Feeling of fullness or a palpable lump in the rectal area. Changes in bowel habits, such as constipation or diarrhea. Unexplained abdominal pain or discomfort. In some cases, no symptoms are present, and the tumor is found incidentally during examinations for other issues.

Diagnostic & Treatment

Diagnosis Path: Diagnosing a benign carcinoid tumor of the rectum typically involves a combination of clinical evaluation and diagnostic tests: - **Digital rectal exam:** Physical examination to feel for abnormal growths. - **Endoscopy:** Visual inspection of the rectum using a flexible fiber-optic instrument, which allows for biopsy. - **Biopsy:** Tissue sample taken during endoscopy for histopathological analysis to confirm the diagnosis. - **Imaging tests:** Techniques such as MRI or CT scans may be used to assess the extent of the tumor and check for spread. - **Laboratory tests:** Measurement of hormone levels in blood or urine, like serotonin, if symptoms suggest hormone secretion. The goal of diagnosis is to confirm the benign nature of the tumor and determine its size and location.

Treatment Protocols: Management of a benign carcinoid tumor of the rectum depends on its size, location, and whether it has spread. Common approaches include: - **Endoscopic removal:** For small tumors confined to the mucosal layer, removal through endoscopy is often sufficient. - **Surgical excision:** Larger or more invasive tumors may require local surgical removal or, in some cases, more extensive surgery. - **Observation:** In cases where the tumor is very small and asymptomatic, careful monitoring may be recommended. - **Follow-up:** Regular check-ups and imaging tests are necessary to monitor for any signs of recurrence or growth. Since benign carcinoid tumors are less likely to spread, the prognosis is generally favorable following appropriate removal.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D3A.026 a billable ICD-10 code?
Yes, D3A.026 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D3A.026?
Clinical documentation must specify the nature of Benign carcinoid tumor of the rectum and any associated comorbidities for accurate reporting.

Cite this Clinical Reference